170 related articles for article (PubMed ID: 36289662)
1. Next-Generation SINE Compound KPT-8602 Ameliorates Dystrophic Pathology in Zebrafish and Mouse Models of DMD.
English KG; Reid AL; Samani A; Coulis GJF; Villalta SA; Walker CJ; Tamir S; Alexander MS
Biomedicines; 2022 Sep; 10(10):. PubMed ID: 36289662
[TBL] [Abstract][Full Text] [Related]
2. The SINE Compound KPT-350 Blocks Dystrophic Pathologies in DMD Zebrafish and Mice.
Hightower RM; Reid AL; Gibbs DE; Wang Y; Widrick JJ; Kunkel LM; Kastenschmidt JM; Villalta SA; van Groen T; Chang H; Gornisiewicz S; Landesman Y; Tamir S; Alexander MS
Mol Ther; 2020 Jan; 28(1):189-201. PubMed ID: 31628052
[TBL] [Abstract][Full Text] [Related]
3. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.
Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM
Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological Inhibition of PKCθ Counteracts Muscle Disease in a Mouse Model of Duchenne Muscular Dystrophy.
Marrocco V; Fiore P; Benedetti A; Pisu S; Rizzuto E; Musarò A; Madaro L; Lozanoska-Ochser B; Bouché M
EBioMedicine; 2017 Feb; 16():150-161. PubMed ID: 28089792
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A
Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083
[TBL] [Abstract][Full Text] [Related]
6. Human dystrophin expressing chimeric (DEC) cell therapy ameliorates cardiac, respiratory, and skeletal muscle's function in Duchenne muscular dystrophy.
Siemionow M; Langa P; Harasymczuk M; Cwykiel J; Sielewicz M; Smieszek J; Heydemann A
Stem Cells Transl Med; 2021 Oct; 10(10):1406-1418. PubMed ID: 34291884
[TBL] [Abstract][Full Text] [Related]
7. Mineralocorticoid receptor antagonism by finerenone is sufficient to improve function in preclinical muscular dystrophy.
Lowe J; Kolkhof P; Haupt MJ; Peczkowski KK; Rastogi N; Hauck JS; Kadakia FK; Zins JG; Ciccone PC; Smart S; Sandner P; Raman SV; Janssen PML; Rafael-Fortney JA
ESC Heart Fail; 2020 Dec; 7(6):3983-3995. PubMed ID: 32945624
[TBL] [Abstract][Full Text] [Related]
8. TIPE2 gene transfer with adeno-associated virus 9 ameliorates dystrophic pathology in mdx mice.
Gao S; Lu A; Amra S; Guo P; Huard J
Hum Mol Genet; 2019 May; 28(10):1608-1619. PubMed ID: 30608588
[TBL] [Abstract][Full Text] [Related]
9. Dystrophic Dmd
Krishnan VS; Thanigaiarasu LP; White R; Crew R; Larcher T; Le Guiner C; Grounds MD
Mol Cell Neurosci; 2020 Oct; 108():103549. PubMed ID: 32890728
[TBL] [Abstract][Full Text] [Related]
10. P2RX7 purinoceptor: a therapeutic target for ameliorating the symptoms of duchenne muscular dystrophy.
Sinadinos A; Young CN; Al-Khalidi R; Teti A; Kalinski P; Mohamad S; Floriot L; Henry T; Tozzi G; Jiang T; Wurtz O; Lefebvre A; Shugay M; Tong J; Vaudry D; Arkle S; doRego JC; Górecki DC
PLoS Med; 2015 Oct; 12(10):e1001888. PubMed ID: 26461208
[TBL] [Abstract][Full Text] [Related]
11. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
12. PDE10A Inhibition Reduces the Manifestation of Pathology in DMD Zebrafish and Represses the Genetic Modifier PITPNA.
Lambert MR; Spinazzola JM; Widrick JJ; Pakula A; Conner JR; Chin JE; Owens JM; Kunkel LM
Mol Ther; 2021 Mar; 29(3):1086-1101. PubMed ID: 33221436
[TBL] [Abstract][Full Text] [Related]
13. Muscle Pathology in Dystrophic Rats and Zebrafish Is Unresponsive to Taurine Treatment, Compared to the
Terrill JR; Huchet C; Le Guiner C; Lafoux A; Caudal D; Tulangekar A; Bryson-Richardson RJ; Sztal TE; Grounds MD; Arthur PG
Metabolites; 2023 Feb; 13(2):. PubMed ID: 36837851
[TBL] [Abstract][Full Text] [Related]
14. Sildenafil reduces respiratory muscle weakness and fibrosis in the mdx mouse model of Duchenne muscular dystrophy.
Percival JM; Whitehead NP; Adams ME; Adamo CM; Beavo JA; Froehner SC
J Pathol; 2012 Sep; 228(1):77-87. PubMed ID: 22653783
[TBL] [Abstract][Full Text] [Related]
15. Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy.
Pinniger GJ; Terrill JR; Assan EB; Grounds MD; Arthur PG
J Physiol; 2017 Dec; 595(23):7093-7107. PubMed ID: 28887840
[TBL] [Abstract][Full Text] [Related]
16. The location of protein oxidation in dystrophic skeletal muscle from the mdx mouse model of Duchenne muscular dystrophy.
Iwasaki T; Terrill JR; Kawarai K; Miyata Y; Tagami T; Maeda N; Hasegawa Y; Watanabe T; Grounds MD; Arthur PG
Acta Histochem; 2022 Dec; 124(8):151959. PubMed ID: 36270048
[TBL] [Abstract][Full Text] [Related]
17. Acute AT
Meyers TA; Heitzman JA; Krebsbach AM; Aufdembrink LM; Hughes R; Bartolomucci A; Townsend D
J Mol Cell Cardiol; 2019 Mar; 128():51-61. PubMed ID: 30664850
[TBL] [Abstract][Full Text] [Related]
18. A new therapeutic effect of simvastatin revealed by functional improvement in muscular dystrophy.
Whitehead NP; Kim MJ; Bible KL; Adams ME; Froehner SC
Proc Natl Acad Sci U S A; 2015 Oct; 112(41):12864-9. PubMed ID: 26417069
[TBL] [Abstract][Full Text] [Related]
19. Dystrophic cardiomyopathy: role of the cardiac myofilaments.
George TG; Hanft LM; Krenz M; Domeier TL; McDonald KS
Front Physiol; 2023; 14():1207658. PubMed ID: 37362434
[TBL] [Abstract][Full Text] [Related]
20. Lipin1 plays complementary roles in myofibre stability and regeneration in dystrophic muscles.
Jama A; Alshudukhi AA; Burke S; Dong L; Kamau JK; Voss AA; Ren H
J Physiol; 2023 Mar; 601(5):961-978. PubMed ID: 36715084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
